UNSPSC 85436006: The diagnosis of other adverse effects

In this classification, this covers the group of activities that yields a diagnosis of other adverse effects, not elsewhere classified. Other adverse effects, not elsewhere classified is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code T78.8.

UNSPSC 85436006 The diagnosis of other adverse effects (Commodity) shows minimal alignment between its nominal scope and recent state and local solicitation activity. The three most recent opportunities posted under this code do not involve diagnosing adverse effects; instead, they describe Diagnostic Imaging Picture Archiving and Communication System (PACS) implementation, special education contracted services across multiple disciplines, and temporary health professional staffing placement in ancillary clinical categories. The code appears to have been applied inconsistently or incorrectly to these opportunities, which span healthcare delivery infrastructure, school district personnel services, and workforce staffing rather than any unified diagnosis-focused service line. State and local governments are using this code tag for episodic solicitations that do not cluster around a coherent procurement pattern.

The recent activity spans three jurisdictions: San Mateo County, California (San Mateo Medical Center PACS implementation, RFP due October 21, 2026); Birdville Independent School District in northeast Texas (special education contracted services, RFQ due October 21, 2026, estimated contract value $398,494.30); and Santa Clara County, California (temporary health professional staffing qualification pool, non-exclusive multiple-award vehicle, RFQ closed October 7, 2026). No repeat buyers or geographic concentration appears in the limited recent record. The code shows no coherent purchasing activity that aligns with its stated taxonomy name, and pursuing opportunities under this code would require confirming that each individual solicitation genuinely relates to adverse-effect diagnosis rather than relying on the code classification itself.